Spero Therapeutics Inc (NASDAQ:SPRO) currently has a daily average trading volume of 129.39K but it saw 182328149 shares traded in last market. With a market cap of 131.39M USD, the company’s current market price of $2.35 came rising about 244.57 while comparing to the previous closing price of $0.68. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.53 and as low as $0.51. In the recent trading on the day, stock has struck highest price mark of $1.85 while lowest mark touched by it was $2.48.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Evercore ISI which downgraded the stock as “In-line” in its note to investors issued on December 20, 2024, recommending a price target of $5 for it. Evercore ISI upgraded its recommendation for the stock as a “Outperform” from “In-line” on September 23, 2022 while assigning a price target range of $2-$8.
Over the week, SPRO’s stock price is moving 245.49% up while it is 230.99% when we observe its performance for the past one month. Year-to-date it is 128.16% up and over the past year, the stock is showing an upside performance of 58.78%.
Currently, Spero Therapeutics Inc’s total number of outstanding shares is 55.90M with 24.32% of that held by the insiders while 23.25% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -193.90% and return on equity (ROE) at -107.28%. Stock’s beta reads 0.25. Stock has a price to book (P/B) ratio of 3.89 while price to sale or P/S ratio amounts to 4.64. Its return on asset (ROA) is -56.85% on average.
